NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) and Chemveda Life Sciences are very pleased to announce the successful chemical synthesis of a unique natural compound that has shown remarkable efficacy as a potential chemotherapy for the treatment of liver cancer. This is a significant advancement for Q BioMed's portfolio asset "Ut

SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the results from EPOCH 2, a Phase 3 study of the investigational agent HTX-011 in o

FAIRLAWN, Ohio, Aug. 20, 2019 /PRNewswire/ -- Two surgical innovations developed by Crystal Clinic Orthopaedic Center are advancing care for patients with anterior cruciate ligament (ACL) injuries and cartilage loss in joints through the use of biologic therapy. These advancements promote the body's natural ability to heal, and provide a simpler, more cost

TUCSON, Ariz., Aug. 20, 2019 /PRNewswire/ -- AQUALUNG THERAPEUTICS CORPORATION receives a $225,000 National Institutes of Health (NIH) (award number R41 HL147769-01) Grant to establish a novel panel of Acute Respiratory Distress Syndrome (ARDS) biomarkers (CRIT-ICU Panel) that stratifies subjects at risk for ARDS into high and low morta

MORGAN HILL, Calif., Aug. 20, 2019 /PRNewswire/ -- Paramit Corporation, a leading developer and manufacturer of medical devices and life science instruments, is pleased to announce the ap

CHICAGO, Aug. 20, 2019 /PRNewswire/ -- Vyaire Medical, Inc., the healthcare industry's dedicated "breathing company," today announced the U.S. Food and Drug Administration (FDA) has granted FDA 510(k) clearance for two of its latest Pulmonary Function Testing (PFT) technologies: Vyntus ONE, Vyntus BODY with SentrySuite Software. The Vyntus ONE is designe

PALO ALTO, Calif., Aug. 20, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for peginterferon lambda (Lambda) for the treatment of hepatitis de

BOSTON, Aug. 20, 2019 /PRNewswire/ -- The state of Georgia has approved Seniorlink to launch Structured Family Caregiving (SFC), a new family caregiver support program. The program offers a digital coaching solution and financial support to families caring for loved ones at home.

SAN JOSE, Calif., Aug. 20, 2019 /PRNewswire/ -- Two experienced healthtech industry leaders today announced the launch of MDisrupt, the first medical diligence company for the healthtech industry. The new service aims to help investors make wiser bets, assure healthtech entrepreneurs they are on track for market adoption, and steer self-insured employers and commerc

COSTA MESA, Calif., Aug. 20, 2019 /PRNewswire/ -- Despite the looming threat of disruption at the hands of e-commerce, the U.S. pharmacy industry continues to enjoy superior levels of customer satisfaction in both the brick-and-mortar and mail order segments, according to the J.D. Power 2019 U.S. Pharmacy Study,SM released today.